Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$113.31 - $150.51 $6.97 Million - $9.25 Million
-61,483 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$115.0 - $141.58 $894,470 - $1.1 Million
7,778 Added 14.48%
61,483 $8.47 Million
Q1 2019

May 10, 2019

BUY
$98.85 - $134.59 $2.11 Million - $2.87 Million
21,300 Added 65.73%
53,705 $6.69 Million
Q4 2018

Jan 31, 2019

BUY
$63.81 - $109.82 $2.07 Million - $3.56 Million
32,405 New
32,405 $3.11 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $33.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.